Drug intelligence / Profile preview

bitongning capsule

Development stage: Unknown
Lead developer: Guangzhou Hengba Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Bitongning Capsule (痹痛宁胶囊) is a Traditional Chinese Medicine (TCM) developed by Guangzhou Hengba Pharmaceutical for the treatment of arthralgia and bi-syndrome. Formulated as an oral capsule, it is designed to dispel wind, eliminate dampness, and resolve blood stasis to alleviate joint pain and swelling. The preparation typically incorporates processed herbal components such as *Strychnos nux-vomica*, *Ephedra*, and *Atractylodes*, which provide analgesic and anti-inflammatory properties. It is primarily indicated for conditions characterized by joint stiffness, pain, and reduced mobility, often associated with chronic rheumatic conditions such as rheumatoid arthritis and osteoarthritis.

Brand names: Bitongning Capsule痹痛宁胶囊
Other names: Bitongning Jiaonang

Beyond the preview

Go deeper on bitongning capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on bitongning capsule.

Explore the full profile